Skip to main content
Erschienen in: Supportive Care in Cancer 1/2011

01.01.2011 | Short Communication

Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender

verfasst von: Jennifer Barsky Reese, Rebecca A. Shelby, Amy P. Abernethy

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sexual concerns are understudied and undertreated for patients with lung cancer. Objectives were to: (1) assess sexual concerns in lung cancer patients and examine differences by age and gender; (2) examine stability of sexual concerns over time; and (3) evaluate whether sexual concerns in lung cancer patients are significantly related to physical and emotional symptoms.

Materials and methods

Data were collected from lung cancer patients during four outpatient clinic visits over 6 months. Measures included sexual concerns (reduced sexual enjoyment, interest, or performance), fatigue (FACIT Fatigue Scale), shortness of breath, and emotional distress (acute distress, despair; Patient Care Monitor). Linear mixed model analyses were conducted.

Results

Sexual concerns were common, with 52% of patients reporting at least mild sexual concerns and were stable. Sexual concerns were significantly associated with physical and emotional symptoms; particularly strong relationships were found between sexual concerns and shortness of breath and emotional distress. Age moderated the relationship between both fatigue and shortness of breath and sexual concerns; gender moderated the relationship between emotional distress and sexual concerns.

Conclusions

Self-reported sexual concerns are common in people with lung cancer, are stable, and are related significantly to physical and emotional symptoms; age and gender influence the distress associated with sexual symptoms in this population. Better attention to patient concerns, treatment, and more research are clearly needed.
Literatur
1.
Zurück zum Zitat Abernethy AP, Herndon JE 2nd, Wheeler JL, Patwardhan M, Shaw H, Lyerly HK, Weinfurt K (2008) Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res 43:1975–1991CrossRefPubMed Abernethy AP, Herndon JE 2nd, Wheeler JL, Patwardhan M, Shaw H, Lyerly HK, Weinfurt K (2008) Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv Res 43:1975–1991CrossRefPubMed
2.
Zurück zum Zitat Abernethy AP, Herndon JE II, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK (2009) Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manage 37:1027–1038CrossRefPubMed Abernethy AP, Herndon JE II, Wheeler JL, Day JM, Hood L, Patwardhan M, Shaw H, Lyerly HK (2009) Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manage 37:1027–1038CrossRefPubMed
3.
Zurück zum Zitat Abernethy AP, Zafar SY, Uronis H, Wheeler JL, Coan A, Rowe K, Herndon JE (2010) Validation of the patient care monitor (version 2.0), a review of systems assessment instrument for cancer patients. J Pain Symptom Manage. doi:10.1016/j.jpainsymman.2010.01.017 Abernethy AP, Zafar SY, Uronis H, Wheeler JL, Coan A, Rowe K, Herndon JE (2010) Validation of the patient care monitor (version 2.0), a review of systems assessment instrument for cancer patients. J Pain Symptom Manage. doi:10.​1016/​j.​jpainsymman.​2010.​01.​017
4.
Zurück zum Zitat Fortner B, Okon T, Schwartzberg L, Tauer K, Houts AC (2003) The cancer care monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 26:1077–1092CrossRefPubMed Fortner B, Okon T, Schwartzberg L, Tauer K, Houts AC (2003) The cancer care monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J Pain Symptom Manage 26:1077–1092CrossRefPubMed
5.
Zurück zum Zitat Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387CrossRefPubMed Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387CrossRefPubMed
6.
Zurück zum Zitat Hoffman AJ, Given BA, von Eye A, Gift AG, Given CW (2007) Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum 34:785–792CrossRefPubMed Hoffman AJ, Given BA, von Eye A, Gift AG, Given CW (2007) Relationships among pain, fatigue, insomnia, and gender in persons with lung cancer. Oncol Nurs Forum 34:785–792CrossRefPubMed
7.
Zurück zum Zitat Knight SJ, Latini DM (2009) Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences. Cancer J 15:41–44CrossRefPubMed Knight SJ, Latini DM (2009) Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences. Cancer J 15:41–44CrossRefPubMed
8.
Zurück zum Zitat Meyerowitz BE, Desmond KA, Rowland JH, Wyatt GE, Ganz PA (1999) Sexuality following breast cancer. J Sex Marital Ther 25:237–250CrossRefPubMed Meyerowitz BE, Desmond KA, Rowland JH, Wyatt GE, Ganz PA (1999) Sexuality following breast cancer. J Sex Marital Ther 25:237–250CrossRefPubMed
9.
Zurück zum Zitat Raudenbush SB, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods. Sage, Thousand Oaks Raudenbush SB, Bryk AS (2002) Hierarchical linear models: applications and data analysis methods. Sage, Thousand Oaks
10.
Zurück zum Zitat Reese JB, Shelby R, Keefe FJ, Porter LS, Abernethy AP (2010) Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. Support Care Cancer 18:1179–1189CrossRefPubMed Reese JB, Shelby R, Keefe FJ, Porter LS, Abernethy AP (2010) Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. Support Care Cancer 18:1179–1189CrossRefPubMed
11.
Zurück zum Zitat Sarna L (1993) Correlates of symptom distress in women with lung cancer. Cancer Pract 1:21–28PubMed Sarna L (1993) Correlates of symptom distress in women with lung cancer. Cancer Pract 1:21–28PubMed
12.
Zurück zum Zitat Sarna L, Brown JK, Cooley ME, Williams RD, Chernecky C, Padilla G, Danao LL (2005) Quality of life and meaning of illness of women with lung cancer. Oncol Nurs Forum 32:E9–E19CrossRefPubMed Sarna L, Brown JK, Cooley ME, Williams RD, Chernecky C, Padilla G, Danao LL (2005) Quality of life and meaning of illness of women with lung cancer. Oncol Nurs Forum 32:E9–E19CrossRefPubMed
13.
Zurück zum Zitat Shell JA, Carolan M, Zhang Y, Meneses KD (2008) The longitudinal effects of cancer treatment on sexuality in individuals with lung cancer. Oncol Nurs Forum 35:73–79CrossRefPubMed Shell JA, Carolan M, Zhang Y, Meneses KD (2008) The longitudinal effects of cancer treatment on sexuality in individuals with lung cancer. Oncol Nurs Forum 35:73–79CrossRefPubMed
14.
Zurück zum Zitat Smith EL, Hann DM, Ahles TA, Furstenberg CT, Mitchell TA, Meyer L, Maurer LH, Rigas J, Hammond S (2001) Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage 21:323–329CrossRefPubMed Smith EL, Hann DM, Ahles TA, Furstenberg CT, Mitchell TA, Meyer L, Maurer LH, Rigas J, Hammond S (2001) Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage 21:323–329CrossRefPubMed
15.
Zurück zum Zitat Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74CrossRefPubMed Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63–74CrossRefPubMed
Metadaten
Titel
Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender
verfasst von
Jennifer Barsky Reese
Rebecca A. Shelby
Amy P. Abernethy
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-1000-0

Weitere Artikel der Ausgabe 1/2011

Supportive Care in Cancer 1/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.